Cardiogenomics Testing Panels Market Forecast: What to Expect by 2029

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

#What Is The Projected Market Size Of The Cardiogenomics Testing Panels Market By 2029?

The cardiogenomics testing panels market has experienced significant expansion in recent years. It is anticipated to increase from $1.38 billion in 2024 to $1.55 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 12.7%. The market’s past growth can be attributed to several factors, including the expansion of reimbursement policies for genetic tests, a rise in genetic counseling services, an enhanced focus on early diagnosis and prevention, increasing public awareness initiatives, and the broader acceptance of telemedicine and remote diagnostics.

The cardiogenomics testing panels market is anticipated to experience significant expansion in the upcoming years. This market is projected to reach $2.48 billion by 2029, growing at a compound annual growth rate (CAGR) of 12.4%. The expansion over the forecast period is driven by the increasing occurrence of cardiovascular diseases, heightened understanding of genetic predispositions, a rising need for personalized medicine, greater access to next-generation sequencing, and increased healthcare spending in genomics. Prominent trends for the forecast period include continuous developments in next-generation sequencing, the adoption of artificial intelligence for data analysis, the creation of comprehensive multi-gene panels, improvements in microarray technology, and the incorporation of genomic data into electronic health records.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28157&type=smp

What Are The Main Drivers Boosting The Cardiogenomics Testing Panels Industry’s Expansion?

The increasing prevalence of inherited cardiovascular diseases is anticipated to drive the growth of the cardiogenomics testing panels market in the coming years. Inherited cardiovascular diseases (ICDs) are a category of heart and blood vessel disorders passed down genetically from parents to children. The rise in these conditions is largely attributable to progress in genetic testing and diagnostics, which enable more accurate detection of previously undiagnosed cases. Cardiogenomics testing panels play a crucial role in addressing inherited cardiovascular diseases by analyzing a patient’s genes to identify mutations responsible for hereditary heart conditions, thereby facilitating early diagnosis, risk assessment, and personalized treatment strategies. For instance, in February 2025, according to the Joint Strategic Needs Assessment, a UK-based community health center, in 2023, Blackpool recorded 185 deaths from cardiovascular disease, compared to 178 deaths in 2022. Thus, the growing occurrence of inherited cardiovascular diseases is a primary driver for the expansion of the cardiogenomics testing panels market.

What Are The Segment Types Shaping The Cardiogenomics Testing Panels Market?

The cardiogenomics testing panels market covered in this report is segmented as

1) By Product Type: Single-Gene Panels, Multi-Gene Panels, Whole Exome Sequencing Panels

2) By Technology: Next-Generation Sequencing, PCR-Based Testing, Microarray, Other Technologies

3) By Application: Inherited Cardiovascular Diseases, Arrhythmias, Cardiomyopathies, Congenital Heart Diseases, Other Appications

4) By End User: Hospitals And Clinics, Diagnostic Laboratories, Academic And Research Institutes, Other End Users

Subsegments:

1) By Single-Gene Panels: Ion Channel Gene Panels, Structural Heart Disease Gene Panels, Arrhythmia Gene Panels

2) By Multi-Gene Panels: Cardiomyopathy Panels, Arrhythmia Panels, Congenital Heart Disease Panels

3) By Whole Exome Sequencing Panels: Targeted Cardiovascular Exome Panels, Comprehensive Exome Panels, Research-Oriented Exome Panels

Who Are The Prominent Global Companies Shaping The Cardiogenomics Testing Panels Market?

Major companies operating in the cardiogenomics testing panels market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific, Inc., Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Eurofins Scientific SE, Illumina Inc., Actia Group, Invitae Corporation, Fulgent Genetics Inc., GeneDx Inc., Ambry Genetics Corporation, Helix OpCo Inc., Centogene Gmbh, Blueprint Genetics Inc., Strand Life Sciences Pvt. Ltd., Genes2Me Pvt. Ltd., BioAro Inc., GENinCode Plc, Igenomix S.L., Asper Biotech Ltd.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/cardiogenomics-testing-panels-global-market-report

Which Region Is Projected To Lead The Cardiogenomics Testing Panels Market During The Forecast Period?

North America was the largest region in the cardiogenomics testing panels market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in cardiogenomics testing panels report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Request A Customized Version Of The Cardiogenomics Testing Panels Market Report:

https://www.thebusinessresearchcompany.com/customise?id=28157&type=smp

Browse Through More Reports Similar to the Global Cardiogenomics Testing Panels Market 2025, By The Business Research Company

Cardiac Biomarkers Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cardiac-biomarkers-global-market-report

Cardiac Biomarkers Testing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cardiac-biomarkers-testing-global-market-report

Pharmacogenomics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/pharmacogenomics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795